mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.094 |
0.07 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |